Select Page

As a leading healthcare market research agency, APLUSA has extensive experience researching diseases within hemato-oncology.

Mockup Hemato-Oncology EN hubspot
Based on APLUSA's research this eBook provides you with an overview of the key stakeholders and treatment options available for four of the most common malignancies in hemato-oncology:
  • Chronic lymphocytic leukemia (CLL)
  • Acute myeloid leukemia (AML)
  • Diffuse large B-Cell lymphoma (DLBCL)
  • Multiple myeloma (MM)